| Project/Area Number |
07670585
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Gastroenterology
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
SASAKI Yutaka Osaka University, Medical School, Assistant Professor, 医学部, 助手 (70235282)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
HAGIWARA Hideki Osaka University, Medical School, Medical Staff, 医学部・附属病院, 医員
MITA Eiji Osaka University, Medical School, Medical Staff, 医学部・附属病院, 医員
KASAHARA Akinori Osaka University, Medical School, Assistant Professor, 医学部, 助手 (70214286)
|
|---|
| Project Period (FY) |
1995 – 1996
|
| Project Status |
Completed (Fiscal Year 1996)
|
| Budget Amount *help |
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1996: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1995: ¥1,500,000 (Direct Cost: ¥1,500,000)
|
|---|
| Keywords | Intracellular signal transduction / Gene therapy / Liver cancer |
|---|
| Research Abstract |
The present study was aimed to elucidate the signal transduction therapy for human liver cancer. For the first experiment, we analyzed the activation of mitogen-activated protein kinase (MAPK) cascade, an intracellular signal trnasduction system involved in normal cell growth, in human liver cancerous tissues. MAPK activity was more enhanced in cancerous tissues than in adjacent non-cancerous tissues. While Raf-1 kinase, which is one of the upstream components of MAPK cascade, exhibited no significant difference in activity between cancerous and non-cancerous tissues, MEK kinase, which can activate MAPK,was increased in activity in cancerous tissues. These findings indicate that MAPK is consititutively activated in cancerous tissues in a different fashion from normal cell growth of the liver. MAPK has been previously reported to induce gene expression of transcriptional factor, followed by gene expression of the cell cycle-related genes. In human liver cancer, c-fos and c-jun expressio
… More
n were enhanced, accompanied by increase in cyclin D1 gene expression.
Next experiment was attempted to examine which component (s) of signal transduction pathway may account for the activation of MAPK cascade in the cancerous tissues of the liver. We focus on the role of IRS-1 (insulin receptor substrate-1), a signal transducing molecule which is activated by insulin or IGF-1 and can activate MAPK cascade. The observation that IRS-1 was over-expressed and activated in liver cancers led us to construct the stable transfectant to see transformation capability of IRS-1. Stable transfectant exhibited MAPK activation, leading to tumor formation in nude mice as well as soft agar. These findings indicate that IRS-1 may contribute to liver cancer cell growth in term of activation of MAPK cascade. In conclusion, the present study suggests the possibility of signal trnasduction therapy for the prevention of cancerous cell growth of the liver by means of the inhibition of signal trnasdcution pathways. Less
|
